4//SEC Filing
Labinger Barry 4
Accession 0000899243-20-021901
CIK 0001651431other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 6:00 PM ET
Size
5.6 KB
Accession
0000899243-20-021901
Insider Transaction Report
Form 4
Labinger Barry
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-08-06+445,819→ 445,819 totalExercise: $15.00Exp: 2030-08-05→ Common Stock (445,819 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vest and become exercisable on August 6, 2021 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
Checkmate Pharmaceuticals, Inc.
CIK 0001651431
Entity typeother
Related Parties
1- filerCIK 0001332456
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 6:00 PM ET
- Size
- 5.6 KB